首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 15 毫秒
1.
参照国外发表的禽网状内皮组织增生病病毒(REV)5’长末端重复序列(LTR)在禽痘病毒(FPV)疫苗株基因组上的整合位点及相关序列,合成一对来自FPV的引物,从国内5个不同厂家生产的禽痘疫苗中经PCR均扩增到REV-5’LTR。通过序列比较发现,我国5个FPV疫苗毒株中REV-5’LTR整合位点与美国和澳大利亚的天然重组禽痘疫苗完全一致。其中,有3个的REV-5’LTR插入序列也与美国的Vac-3-Am株和澳大利亚的Vac-M3-Au株有100%的同源性。另2个中国疫苗毒株中的REV.LTR插入序列与美国疫苗毒株Vac-1-A。中的REV-LTR插入序列有99.6%的同源性。但是,这5个中国禽痘疫苗毒株中整合的REVLTR与中国近年分离到的REV野毒株HA9901的5’LTR的同源性只有75.4%-92.4%。  相似文献   

2.
将国内5个不同生产厂家来源的禽痘弱毒疫苗株和1株禽痘野毒株在鸡胚成纤维细胞(CEF)上连续传5代,用禽网状内皮组织增生病病毒(Reticuloendotheliosis virus,REV)特异性的单克隆抗体进行间接免疫荧光试验(Immunonuoreseellee assay,IFA),均检测不到传染性REV。但以6株禽痘病毒(FPV)感染的第2代和第5代细胞基因组提取物为模板,通过PCR均能扩增出REV的长末端重复序列(LTR)和囊膜蛋白(env)基因片段。用特异性核酸探针作分子斑点杂交(Dot blot),结果显示所扩增的PCR条带为特异的REV—LTR和REV—env)基因片段。实验结果表明,国内的一些痘病毒疫苗和野毒株基因组中,已稳定地整合进了REV的基因组成分。  相似文献   

3.
研究去除重组鸡痘病毒中的报告基因,构建一株只含目的基因的重组毒。将H5亚型AIV的HA基因作为靶基因,两侧含loxP序列的GFP表达盒插入鸡痘病毒重组臂基因构建了转移质粒载体,将其与脂质体混合转染CEF细胞,获得了表达H5和GFP的鸡痘病毒重组体。通过二次转染,利用Cre酶自动敲除重组病毒中的GFP基因,最终获得了只含H5血凝素基因表达盒的重组鸡痘病毒。免疫荧光和病毒滴度测定结果表明,经过连续传代后重组病毒仍然稳定复制并表达H5血凝素。用105PFU和2×105PFU rFPV H5免疫SPF鸡,28d后,免疫组鸡抗体平均滴度(HI)分别达到4log 2和4.5log 2,结果表明,H5HA基因重组病毒能刺激鸡群产生较高特异抗体。  相似文献   

4.
5.
Eight stable fowlpox virus (FPV) recombinants which express the envelope glycoprotein of the spleen necrosis virus (SNV) strain of reticuloendotheliosis virus (REV), an avian retrovirus, were constructed. These recombinants differ in the genomic location of the inserted genes, in the orientation of the insert relative to flanking viral sequences, and in the promoter used to drive expression of the env gene. Of these variables, promoter strength seems to be the most crucial. The P7.5 promoter of vaccinia virus, which is commonly used in the construction of both vaccinia virus and FPV recombinants, resulted in lower levels of expression of the envelope antigen in infected chicken cells compared with a strong synthetic promoter, as determined by immunofluorescence and enzyme-linked immunosorbent assay. Two peptides encoded by the env gene, the 21-kDa transmembrane peptide and a 62-kDa precursor, were detected by immunoprecipitation of labeled proteins from cells infected with recombinant FPVs, using monoclonal antibodies against REV. These peptides comigrated with those precipitated from REV-infected cells. One of the recombinants (f29R-SNenv) was used for vaccination of 1-day-old chickens. Vaccinated chicks developed neutralizing antibodies to SNV more rapidly than did unvaccinated controls following SNV challenge and were protected against both viremia and the SNV-induced runting syndrome.  相似文献   

6.
应用RT PCR扩增出新城疫病毒F4 8E8株融合蛋白 (F)基因 ,将其克隆入pGEM Teasyvector构建重组质粒pGEM TF并进行测序确证。分别从pGEM T和pUCHA切下F基因和H9亚型禽流感病毒F株 (A chicken china F 1 998)血凝素 (HA)基因 ,通过一系列分子生物学操作步骤插入到质粒pFPV7S中的鸡痘病毒基因组复制非必需片段构建重组质粒p7SHF ,其中F基因和HA基因分别由鸡痘病毒启动子PE L和合成启动子PS调控。最后将P1 1 LacZ报告基因表达盒插入质粒p7SHF获得转移载体pFPVHF ,用以转染已预先感染鸡痘病毒 2 82E4疫苗株的鸡胚成纤维细胞 (CEF)。通过在含有X Gal的营养琼脂上连续挑选蓝色病毒蚀斑获得并纯化重组病毒。PCR和Southernblot检测证实了F基因和HA基因已插入鸡痘病毒的基因组 ;间接免疫荧光试验结果表明重组病毒能够同时正确表达HA和F蛋白。  相似文献   

7.
CpG methylation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat (LTR) has been implicated in proviral latency, but there is presently little information available regarding the pattern of LTR methylation and its effect on viral gene expression. To gain insight into the mechanisms of HTLV-1 latency, we have studied methylation of individual CpG sites in the U3-R region of the integrated proviral LTR by using bisulfite genomic sequencing methods. Surprisingly, our results reveal selective hypermethylation of the 5' LTR and accompanying hypomethylation of the 3' LTR in both latently infected cell lines and adult T-cell leukemia (ATL) cells having a complete provirus. Moreover, we observed a lack of CpG methylation in the LTRs of 5'-defective proviruses recovered from ATL samples, which is consistent with the selective hypomethylation of the 3' LTR. Thus, the integrated HTLV-1 provirus in these carriers appears to be hypermethylated in the 5' LTR and hypomethylated in the 3' LTR. These results, together with the observation that proviral gene expression is reactivated by 5-azacytidine in latently infected cell lines, indicate that selective hypermethylation of the HTLV-1 5' LTR is common both in vivo and in vitro. Thus, hypermethylation of the 5' LTR appears to be an important mechanism by which HTLV-1 gene expression is repressed during viral latency.  相似文献   

8.
从ConA刺激的鸡脾细胞中扩增出鸡白细胞介素2(ChIL-2)基因编码区。将该编码区Cdna序列和调控其转录的鸡痘病毒早晚期启动子(PE/L)的基因片段定向克隆到鸡痘病毒转移载体p1175中,获得重组转移载体P1175il2,然后转染已感染鸡痘病毒282E4疫苗株(wt-FPV)的鸡胚成纤维细胞(CEF),质粒P1175il2与wt-FPV基因组DNA发生同源重组,产生了表达ChIL-2的重组鸡痘病毒Rfpv-IL2。通过在含X-gal的营养琼脂上连续挑选蓝色病毒蚀斑,获得并纯化重组鸡痘病毒Rfpv-IL2。应用XTT/PMS方法检测的Rfpv-IL2 (M.O.I 2.0)感染CEF 72小时后细胞上清中表达的重组ChIL-2生物活性,效价为3.6×105u/Ml,表明Rfpv-IL2能有效地表达ChIL-2。下一步将利用Rfpv-IL2在体内表达ChIL-2,研究ChIL-2的免疫增强作用及其作用机理。  相似文献   

9.
10.
11.
12.
Poxviruses are renowned for encoding numerous immunomodulatory proteins capable of undermining potent immune defenses. One effective barrier against infection is apoptosis, a process controlled at the mitochondria by pro- and antiapoptotic members of the highly conserved Bcl-2 family of proteins. Although poxviruses are known to encode an array of effective inhibitors of apoptosis, members of the Avipoxvirus genus, which includes fowlpox virus, encode proteins with Bcl-2 homology. Here, we show that FPV039, a fowlpox virus protein with limited Bcl-2 homology, inhibited apoptosis in response to a variety of cytotoxic stimuli, including virus infection itself. Similar to other antiapoptotic Bcl-2 proteins, FPV039 localized predominantly to the mitochondria in both human and chicken cells and protected human cells from tumor necrosis factor alpha-induced loss of the mitochondrial membrane potential. In addition, coimmunoprecipitation revealed that FPV039 interacted constitutively with the proapoptotic Bcl-2 protein, Bak, in both human and chicken cells. Concordantly, FPV039 also inhibited apoptosis induced by the transient overexpression of Bak. To confirm these results in the context of virus infection, we generated a recombinant vaccinia virus lacking F1L, the endogenous apoptotic inhibitor in vaccinia virus, and expressing FPV039. In the context of vaccinia virus infection, FPV039 retained the ability to localize to the mitochondria and interacted with Bak. Moreover, FPV039 prevented the activation of Bak and protected infected cells from apoptosis induced by staurosporine and virus infection. Together, our data indicate that FPV039 is a functional Bcl-2 homologue that inhibits apoptosis by neutralizing the proapoptotic Bcl-2 family member Bak.  相似文献   

13.
将将城疫病毒(NDV)F48E8株融合蛋白基因导入鸡痘病毒(FPV)插入载体pEGF1175-1的P7.5启动子下游,得到转移载体pFG1175-1重组质粒。采用脂质体转染技术,将该质粒转染FPV282E株感染的鸡胚成纤维细胞(CEF)。,经过多次蓝斑筛选纯化,获稳定的重组病毒rFPV-NDF。间接免疫荧光试验表明,rFPV-NDF感染的CEF中表达了NDV的融合蛋白。用rFPV-NDF免疫的SF  相似文献   

14.
15.
The Fusion (F) and Haemagglutinin-Neuraminidase (HN) genes of Newcastle disease virus (NDV) and the glycoprotein B (gB) gene of infectious laryngothracheitis virus (ILTV) as well as a LacZ reporter gene were all inserted into a nonessential gene of fowlpox virus (FPV) 017 strain by homologous recombination. The NDV and ILTV genes were each under the control of a fowlpox virus immediate early/late promoter (LP2EP2), whereas the LacZ reporter gene expression cassette was regulated by a P11 late promoter. A recombinant FPV harboring the F, HN and gB genes as well as the LacZ gene, designated as rFPV-F/HN/gB/LacZ, was obtained after ten cycles of blue plaque purification. The presence of the NDV and ILTV genes was confirmed by PCR. The expression of the recombinant proteins in rFPV-F/HN/gB/LacZ was characterized by Western blot (F and gB proteins) and indirect immunofluorescence tests (F, HN and gB proteins). The results demonstrated that all four foreign proteins, which were encoded within a 10-kb gene fragment, could be expressed authentically and efficiently. Compared with the parental virus, rFPV-F/HN/gB/LacZ showed no obvious difference with respect to virus replication and cytopathogenic effects in the cell culture of chicken embryo fibroblasts (CEF). Overall, this study suggests that FPV can be a useful live virus vector for the expression of multiforeign genes against multiple avian pathogens.  相似文献   

16.
Vaccination against AIDS is hampered by great diversity between human immunodeficiency virus (HIV) strains. Heterologous B-subtype-based simian-human immunodeficiency virus (SHIV) DNA prime and poxvirus boost vaccine regimens can induce partial, T-cell-mediated, protective immunity in macaques. We analyzed a set of DNA, recombinant fowlpox viruses (FPV), and vaccinia viruses (VV) expressing subtype AE HIV type 1 (HIV-1) Tat, Rev, and Env proteins and SIV Gag/Pol in 30 pigtail macaques. SIV Gag-specific CD4 and CD8 T-cell responses were induced by sequential DNA/FPV vaccination, although lower FPV doses, VV/FPV vaccination, and DNA vaccines alone were not as consistently immunogenic. The SHIV AE DNA prime, FPV boost regimens were significantly less immunogenic than comparable B-subtype SHIV vaccination. Peak viral load was modestly (0.4 log10 copies/ml) lower among the AE subtype SHIV-immunized animals compared to controls following the virulent B subtype SHIV challenge. Protection from persistent high levels of viremia and CD4 T-cell depletion was less in AE subtype compared to B subtype SHIV-vaccinated macaques. Gag was highly immunodominant over the other AE subtype SHIV vaccine proteins after vaccination, and this immunodominance was exacerbated after challenge. Interestingly, the lower level of priming of immune responses did not blunt postchallenge Gag-specific recall responses, despite more modest protection. These studies suggest priming of T-cell immunity to prevent AIDS in humans is possible, but differences in the immunogenicity of various subtype vaccines and broad cross-subtype protection are substantial hurdles.  相似文献   

17.
Poxviruses have evolved various strategies to counteract the host immune response, one of which is based on the expression of soluble cytokine receptors. Using various biological assays, we detected a chicken interferon-gamma (chIFN-gamma)-neutralizing activity in supernatants of fowlpox virus (FPV)-infected cells that could be destroyed by trypsin treatment. Secreted viral proteins were purified by affinity chromatography using matrix-immobilized chIFN-gamma, followed by two-dimensional gel electrophoresis. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) analysis indicated that the viral IFN-gamma-binding protein in question was encoded by the FPV gene 016. The chicken IFN-gamma binding and neutralizing activity of the recombinant FPV016 protein was confirmed using supernatants of cells infected with a recombinant vaccinia virus that lacked its own IFN-gamma-binding protein but instead expressed the FPV016 gene. The FPV016 gene product also neutralized the activity of duck and human IFN-gamma but failed to neutralize the activity of mouse and rat IFN-gamma. Unlike previously known cellular and poxviral IFN-gamma receptors, which all contain fibronectin type III domains, the IFN-gamma-binding protein of FPV contains an immunoglobulin domain. Remarkably, it exhibits no significant homology to any known viral or cellular protein. Because IFN-gamma receptors of birds have not yet been characterized at the molecular level, the possibility remains that FPV016 represents a hijacked chicken gene and that avian and mammalian IFN-gamma receptors have fundamentally different primary structures.  相似文献   

18.
目的:为获得能有效预防O型口蹄疫病毒的重组鸡痘病毒活载体疫苗奠定基础。方法:在O型口蹄疫病毒P1-2A基因上游引入Kozak序列,下游通过Linker与细胞因子IL-18联结,获得P1-2A基因与猪IL-18基因融合表达基因盒P1-2A-IL-18,将该表达基因盒克隆至鸡痘病毒中间转移载体pUTAL-3C中,构建重组鸡痘病毒转移载体质粒pUTAL-3C- P1-2A-IL-18。通过脂质体转染法,将pUTAL-3C- P1-2A-IL-18与鸡痘病毒282E4株共转染鸡胚成纤维细胞(CEF),通过BrdU三次加压筛选,挑选出单克隆重组病毒株。结果:经RT-PCR和间接免疫荧光法鉴定,证明所筛选的1株重组鸡痘病毒在CEF中能正确表达P1-2A-IL-18基因盒。结论:成功获得了一株共表达O型口蹄疫病毒P1-2A基因和猪白细胞介素18基因的重组鸡痘毒疫苗候选株rFPV-3C-P1-2A-IL-18。  相似文献   

19.
20.
在克隆和鉴定新城疫病毒(NDV)F48E8株血凝素-神经氨酸酶(HN)基因的基础上,应用分子克隆技术将HN基因导入鸡痘病毒插入载体pFG1175-1中启动子P7.5的下游,得到携带NDV-HN基因的质粒pFGHN1175-1。将此质粒pFGHN1175-1以脂质体转染中国鸡痘病毒疫苗株282E4株感染3 ̄4h的鸡胚成纤维细胞,采用蓝斑筛选方法纯化3次,得到稳定的重组鸡痘病毒。用NDV-HN基因特异  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号